Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 10:03 am Sale | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | PRICE T ROWE ASSOCIATES INC | 3,453,460 4.2% | -642,928 (-15.69%) | View |
| 2024-02-14 07:46 am Purchase | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | RTW INVESTMENTS LP | 6,887,086 8.4% | 2,920,171 (+73.61%) | View |
| 2024-02-13 5:16 pm Purchase | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | VANGUARD GROUP INC | 8,673,432 10.56% | 1,436,909 (+19.86%) | View |
| 2024-02-13 3:41 pm Purchase | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | SANDS CAPITAL MANAGEMENT LLC | 4,118,008 5% | 4,118,008 (New Position) | View |
| 2024-02-08 10:18 am Sale | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | WELLINGTON MANAGEMENT GROUP LLP | 4,415,029 5.38% | -787,655 (-15.14%) | View |
| 2024-01-29 3:26 pm Purchase | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | BlackRock Inc. BLK | 5,238,400 6.4% | 901,908 (+20.80%) | View |
| 2023-09-11 1:33 pm Purchase | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | VANGUARD GROUP INC | 7,236,523 10.12% | 862,293 (+13.53%) | View |
| 2023-02-14 12:38 pm Sale | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | PRICE T ROWE ASSOCIATES INC | 4,096,388 5.8% | -1,579,610 (-27.83%) | View |
| 2023-02-14 10:10 am Purchase | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | RTW INVESTMENTS LP | 3,966,915 5.7% | 3,966,915 (New Position) | View |
| 2023-02-09 11:35 am Purchase | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | VANGUARD GROUP INC | 6,374,230 9.09% | 453,662 (+7.66%) | View |
| 2023-02-06 2:58 pm Purchase | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | WELLINGTON MANAGEMENT GROUP LLP | 5,202,684 7.42% | 3,918,574 (+305.16%) | View |
| 2023-02-03 12:10 pm Purchase | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | BlackRock Inc. BLK | 4,336,492 6.2% | 925,078 (+27.12%) | View |
| 2023-01-10 08:47 am Sale | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | FEDERATED HERMES INC. FHI | 3,094,500 4.41% | -892,370 (-22.38%) | View |
| 2022-12-09 2:31 pm Sale | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | Capital International Investors | 1,711,517 2.4% | -3,917,936 (-69.60%) | View |
| 2022-08-10 2:56 pm Sale | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | PRICE T ROWE ASSOCIATES INC | 5,675,998 8.1% | -5,849,091 (-50.75%) | View |
| 2022-03-09 5:18 pm Sale | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | BlackRock Inc. BLK | 3,411,414 4.9% | -73,238 (-2.10%) | View |
| 2022-02-14 3:02 pm Sale | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | FEDERATED HERMES INC. FHI | 3,986,870 5.85% | -293,658 (-6.86%) | View |
| 2022-02-14 2:34 pm Purchase | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | PRICE T ROWE ASSOCIATES INC | 11,525,089 16.9% | 2,054,597 (+21.69%) | View |
| 2022-02-11 11:19 am Sale | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | Capital International Investors | 5,629,453 8.3% | -1,270,040 (-18.41%) | View |
| 2022-02-10 08:42 am Purchase | 13G | ULTRAGENYX PHARMACEUTICAL INC RARE | VANGUARD GROUP INC | 5,920,568 8.69% | 270,183 (+4.78%) | View |